• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原位小鼠膀胱癌模型的肿瘤形成特征

Tumor establishment features of orthotopic murine bladder cancer models.

作者信息

Lee Jin Seok, Bae Min Ho, Choi Sung Ho, Lee Sang Hun, Cho Young Sam, Park Heung Jae, Kwon Chil Hun, Joo Kwan Joong

机构信息

Department of Urology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Korean J Urol. 2012 Jun;53(6):396-400. doi: 10.4111/kju.2012.53.6.396. Epub 2012 Jun 19.

DOI:10.4111/kju.2012.53.6.396
PMID:22741047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3382688/
Abstract

PURPOSE

Animal tumor models are important for the evaluation of novel therapeutic modalities. Since the initial report of an orthotopic bladder tumor model, several modifications have been proposed to improve the tumor take rate. Here we compared the HCl-pretreated and electrocauterization-pretreated orthotopic murine bladder tumor models.

MATERIALS AND METHODS

MBT-2 murine bladder cancer cells were transurethrally implanted in the bladder of syngeneic C3H/He mice. The mice were divided into three groups according to pretreatment methods (electrocautery, HCl, and control group) and were subjected to pretreatment before instillation of MBT-2 tumor cells into the bladder. Mice were sacrificed on day 21, and bladders were harvested, weighed, and examined histopathologically.

RESULTS

The tumor take rate of the control, electrocautery, and HCl groups was 0%, 54%, and 100%, respectively. The tumor take rate of the HCl group was significantly higher than that of the control group (p<0.01) and the electrocautery group (p=0.01). Pathologic reports revealed that all established bladder tumors were high-grade papillary urothelial carcinomas.

CONCLUSIONS

The HCl pretreatment model was a preferable murine bladder tumor model for evaluating further therapeutic interventions.

摘要

目的

动物肿瘤模型对于评估新型治疗方式很重要。自从原位膀胱肿瘤模型首次报道以来,已提出了几种改进方法以提高肿瘤接种成功率。在此,我们比较了盐酸预处理和电灼预处理的原位小鼠膀胱肿瘤模型。

材料与方法

将MBT-2小鼠膀胱癌细胞经尿道植入同基因C3H/He小鼠的膀胱。根据预处理方法(电灼、盐酸和对照组)将小鼠分为三组,并在将MBT-2肿瘤细胞注入膀胱之前进行预处理。在第21天处死小鼠,取出膀胱,称重,并进行组织病理学检查。

结果

对照组、电灼组和盐酸组的肿瘤接种成功率分别为0%、54%和100%。盐酸组的肿瘤接种成功率显著高于对照组(p<0.01)和电灼组(p=0.01)。病理报告显示,所有已形成的膀胱肿瘤均为高级别乳头状尿路上皮癌。

结论

盐酸预处理模型是用于评估进一步治疗干预措施的更优小鼠膀胱肿瘤模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b4/3382688/2d90257649bf/kju-53-396-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b4/3382688/0fbd8f13528d/kju-53-396-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b4/3382688/2d90257649bf/kju-53-396-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b4/3382688/0fbd8f13528d/kju-53-396-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b4/3382688/2d90257649bf/kju-53-396-g002.jpg

相似文献

1
Tumor establishment features of orthotopic murine bladder cancer models.原位小鼠膀胱癌模型的肿瘤形成特征
Korean J Urol. 2012 Jun;53(6):396-400. doi: 10.4111/kju.2012.53.6.396. Epub 2012 Jun 19.
2
Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model.优化同基因小鼠模型中的原位膀胱肿瘤植入
J Urol. 2009 Dec;182(6):2926-31. doi: 10.1016/j.juro.2009.08.020. Epub 2009 Oct 20.
3
Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model.原位小鼠膀胱癌模型中的膀胱内脂质体介导的白细胞介素-2基因治疗
Gene Ther. 2000 May;7(10):844-51. doi: 10.1038/sj.gt.3301157.
4
Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments.建立用于膀胱内治疗研究的原位小鼠浅表膀胱肿瘤模型。
Hum Cell. 2008 Aug;21(3):57-63. doi: 10.1111/j.1749-0774.2008.00055.x.
5
[Establishment and application of an orthotopic murine bladder cancer model].[原位小鼠膀胱癌模型的建立与应用]
Ai Zheng. 2007 Apr;26(4):341-5.
6
Histopathological characterization of a syngeneic orthotopic murine bladder cancer model.同基因原位小鼠膀胱癌模型的组织病理学特征
Int Braz J Urol. 2008 Mar-Apr;34(2):220-6; discussion 226-9. doi: 10.1590/s1677-55382008000200013.
7
Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model.原位膀胱癌模型中膀胱内双重PI3K/mTOR复合物1/2抑制剂NVP-BEZ235的治疗
Int J Oncol. 2015 Jul;47(1):377-83. doi: 10.3892/ijo.2015.2995. Epub 2015 May 11.
8
Intravesical interleukin-15 gene therapy in an orthotopic bladder cancer model.原位膀胱癌模型中的膀胱内白细胞介素-15 基因治疗。
Hum Gene Ther. 2011 Nov;22(11):1423-32. doi: 10.1089/hum.2011.013. Epub 2011 Jul 8.
9
The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression.通过下调c-myc表达建立生长可控的原位膀胱癌模型。
Oncotarget. 2016 Jul 22;8(31):50500-50509. doi: 10.18632/oncotarget.10784. eCollection 2017 Aug 1.
10
An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment.一种用于高危非肌肉浸润性膀胱癌的小鼠原位异种移植模型:小鼠品系、肿瘤细胞计数、停留时间和膀胱预处理的影响。
BMC Cancer. 2017 Nov 23;17(1):790. doi: 10.1186/s12885-017-3778-3.

引用本文的文献

1
Establishing a standardized murine orthotopic intra-rectal model for the study of colorectal adenocarcinoma.建立用于结直肠癌研究的标准化小鼠直肠原位模型。
J Gastrointest Oncol. 2024 Dec 31;15(6):2578-2587. doi: 10.21037/jgo-24-515. Epub 2024 Dec 9.
2
Preclinical Models for Bladder Cancer Research.膀胱癌研究的临床前模型。
Hematol Oncol Clin North Am. 2021 Jun;35(3):613-632. doi: 10.1016/j.hoc.2021.02.007. Epub 2021 Apr 16.

本文引用的文献

1
Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model.优化同基因小鼠模型中的原位膀胱肿瘤植入
J Urol. 2009 Dec;182(6):2926-31. doi: 10.1016/j.juro.2009.08.020. Epub 2009 Oct 20.
2
Intravesical ultrasonography for tumor staging in an orthotopically implanted rat model of bladder cancer.膀胱内超声检查在膀胱癌原位植入大鼠模型中的肿瘤分期应用
J Urol. 2007 Mar;177(3):1169-73. doi: 10.1016/j.juro.2006.10.038.
3
Intravesical interleukin-12 gene therapy in an orthotopic bladder cancer model.原位膀胱癌模型中的膀胱内白细胞介素-12基因治疗
Urology. 2005 Aug;66(2):461-6. doi: 10.1016/j.urology.2005.03.052.
4
Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice.姜黄素可预防C3H小鼠中MBT-2肿瘤细胞系的膀胱内肿瘤植入。
J Urol. 2001 Oct;166(4):1498-501.
5
Evaluation of gene transfer efficiency by viral vectors to murine bladder epithelium.
J Urol. 2001 Feb;165(2):667-71. doi: 10.1097/00005392-200102000-00091.
6
Role of animal models in understanding intravesical therapy with bacille Calmette-Guérin.动物模型在理解卡介苗膀胱内灌注治疗中的作用。
Clin Infect Dis. 2000 Sep;31 Suppl 3:S106-8. doi: 10.1086/314065.
7
Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model.一种新型可移植原位大鼠膀胱移行细胞肿瘤模型的特征描述。
Br J Cancer. 1999 Oct;81(4):638-46. doi: 10.1038/sj.bjc.6690741.
8
Optimizing syngeneic orthotopic murine bladder cancer (MB49).优化同基因原位小鼠膀胱癌(MB49)。
Cancer Res. 1999 Jun 15;59(12):2834-7.
9
Development of secondary structure, growth characteristics and cytogenetic analysis of human transitional cell carcinoma xenografts in scid/scid mice.人移行细胞癌异种移植瘤在scid/scid小鼠体内的二级结构发育、生长特性及细胞遗传学分析
J Urol. 1996 Mar;155(3):1128-32.
10
Impairment of antibacterial effect of bladder surface mucin by protamine sulfate.硫酸鱼精蛋白对膀胱表面粘蛋白抗菌作用的损害。
J Infect Dis. 1981 Aug;144(2):180. doi: 10.1093/infdis/144.2.180.